BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30558666)

  • 1. Prognostic values of S100 family members in ovarian cancer patients.
    Bai Y; Li LD; Li J; Lu X
    BMC Cancer; 2018 Dec; 18(1):1256. PubMed ID: 30558666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of the expression and prognosis for S100 in human ovarian cancer: A STROBE study.
    Xu HY; Song HM; Zhou Q
    Medicine (Baltimore); 2020 Nov; 99(47):e22777. PubMed ID: 33217795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic values of S100 family mRNA expression in ovarian cancer.
    Ma N; Zhu L; Yang L; Cui Y; Zhan Y
    Cancer Biomark; 2019; 25(1):67-78. PubMed ID: 31033462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct prognostic roles of S100 mRNA expression in gastric cancer.
    Wang C; Luo J; Rong J; He S; Zhang L; Zheng F
    Pathol Res Pract; 2019 Jan; 215(1):127-136. PubMed ID: 30414696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct prognostic values of S100 mRNA expression in breast cancer.
    Zhang S; Wang Z; Liu W; Lei R; Shan J; Li L; Wang X
    Sci Rep; 2017 Jan; 7():39786. PubMed ID: 28051137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic roles of Notch receptor mRNA expression in human ovarian cancer.
    Chen C; Wang X; Huang S; Wang L; Han L; Yu S
    Oncotarget; 2017 May; 8(20):32731-32740. PubMed ID: 28415574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct prognostic values of four-Notch-receptor mRNA expression in ovarian cancer.
    Zhou X; Teng L; Wang M
    Tumour Biol; 2016 May; 37(5):6979-85. PubMed ID: 26662955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New serum tumor markers S100, TFF3 and AIF-1 and their possible use in oncogynecology.
    Maděrka M; Pilka R; Neubert D; Hambálek J
    Ceska Gynekol; 2019; 84(4):303-308. PubMed ID: 31818115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma.
    Zhang Y; Yang X; Zhu XL; Bai H; Wang ZZ; Zhang JJ; Hao CY; Duan HB
    Aging (Albany NY); 2021 Jun; 13(11):15459-15478. PubMed ID: 34148033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100 family members: potential therapeutic target in patients with hepatocellular carcinoma: A STROBE study.
    Zhang C; Yao R; Chen J; Zou Q; Zeng L
    Medicine (Baltimore); 2021 Jan; 100(3):e24135. PubMed ID: 33546025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100-mediated signal transduction in the nervous system and neurological diseases.
    Zimmer DB; Chaplin J; Baldwin A; Rast M
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):201-14. PubMed ID: 16171556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
    Zhang Q; Xia T; Qi C; Du J; Ye C
    BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic values and immune suppression of the S100A family in pancreatic cancer.
    Zhuang H; Chen X; Dong F; Zhang Z; Zhou Z; Ma Z; Huang S; Chen B; Zhang C; Hou B
    J Cell Mol Med; 2021 Mar; 25(6):3006-3018. PubMed ID: 33580614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.
    Gayarre J; Kamieniak MM; Cazorla-Jiménez A; Muñoz-Repeto I; Borrego S; García-Donas J; Hernando S; Robles-Díaz L; García-Bueno JM; Ramón Y Cajal T; Hernández-Agudo E; Heredia Soto V; Márquez-Rodas I; Echarri MJ; Lacambra-Calvet C; Sáez R; Cusidó M; Redondo A; Paz-Ares L; Hardisson D; Mendiola M; Palacios J; Benítez J; García MJ
    J Gynecol Oncol; 2016 Jan; 27(1):e7. PubMed ID: 26463438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic values of signal transducers activators of transcription family in ovarian cancer.
    Li S; Sheng B; Zhao M; Shen Q; Zhu H; Zhu X
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28536310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.
    Lokman NA; Pyragius CE; Ruszkiewicz A; Oehler MK; Ricciardelli C
    Transl Res; 2016 May; 171():83-95.e1-2. PubMed ID: 26925708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.
    Bai Y; Li LD; Li J; Lu X
    J Ovarian Res; 2016 Jun; 9(1):35. PubMed ID: 27315793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Integrated Bioinformatic Analysis of the S100 Gene Family for the Prognosis of Colorectal Cancer.
    Zeng ML; Zhu XJ; Liu J; Shi PC; Kang YL; Lin Z; Cao YP
    Biomed Res Int; 2020; 2020():4746929. PubMed ID: 33294444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Expression of
    Zou R; Xu H; Li F; Wang S; Zhu L
    DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic values of the peroxiredoxins family in ovarian cancer.
    Li S; Hu X; Ye M; Zhu X
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30104402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.